Genomic Valley Biotech Ltd
Genomic Valley Biotech Ltd (539206): company summary
Genomic Valley Biotech Ltd (539206) is a micro-cap Healthcare company valued at ₹9 crore operating in Biotechnology on the NSE and BSE.
Genomic Valley Biotech Ltd (539206) is a micro-cap Healthcare company valued at ₹9 crore operating in Biotechnology on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -53.7% a year over three years; profit fell 64.1% a year, behind revenue — margins are under pressure. Return on equity is 0.8%.
- Valuation multiples
- The stock trades at 282.5 times earnings, a premium to the Healthcare median of 32.5, 2.20 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Held back by valuation (0.0). Scored on 4 of 5 measures.
DocStoX score
Medium confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Healthy net margin (43%)
- Low leverage — D/E 0.00
- Profit shrinking 64% a year
- Valuation is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Biotechnology
Explore Genomic Valley Biotech Ltd’s valuation
Free deep-dive tools · no sign-up
Genomic Valley Biotech Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Genomic Valley Biotech Ltd with peers
Related tools & concepts
Value Genomic Valley Biotech Ltd with the ratios and calculators DocStoX uses in its analysis.

